Non-Muscle Invasive Bladder Urothelial Carcinoma (DBCOND0136858)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05521698	Study to Determine Possible Effects of Apalutamide on EGFR Expression in Patients With Non-muscle Invasive Bladder Cancer	Apalutamide	basic_science	1	not_yet_recruiting
NCT05962541	Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)	Hexaminolevulinate	treatment	4	not_yet_recruiting
NCT06503614	A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer	Durvalumab Monalizumab	treatment	2	not_yet_recruiting
NCT06396533	Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)	No drug interventions	Not Available	Not Available	active_not_recruiting
NCT06020807	Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer	No drug interventions	Not Available	Not Available	completed
NCT06167356	Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.	No drug interventions	Not Available	Not Available	recruiting
NCT04730232	Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable	Paclitaxel Tislelizumab	treatment	2	unknown_status
NCT05946369	Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer	No drug interventions	Not Available	Not Available	completed